Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.01 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.099 | 0.02 |